Procter & Gamble, one of the largest chemical manufacturers of personal care products in the world, has issued a sweeping recall for 32 widely used brands due to the detected presence of the cancer-linked chemical benzene.
The voluntary recall impacts numerous recognized products, such as: Pantene, Herbal Essence, Aussie and Old Spice. The full list is available on the FDA website. The company explained the reason for the recall in an announcement.
“The Procter & Gamble Company (NYSE: PG) today issued a voluntary product recall to the consumer level of aerosol dry conditioner spray products and aerosol dry shampoo spray products from Pantene, Aussie, Herbal Essences, and Waterless produced in the United States, in addition to previously discontinued aerosol dry shampoo products from Old Spice and Hair Food, due to the presence of benzene detected in some products,” the company said.
It provided a reason in a “risk statement” about the detected presence of benzene in the products.
“Risk Statement: Benzene is classified as a human carcinogen,” the company said. “Exposure to benzene can occur by inhalation, orally, and through the skin and it can result in cancers including leukemia and blood cancer of the bone marrow and blood disorders which can be life-threatening.”
“Based on exposure modeling and the cancer risk assessments published by the Environmental Protection Agency (EPA) (IRIS database), daily exposure to benzene in the recalled products at the levels detected in our testing would not be expected to cause adverse health consequences,” the company added. “Benzene is ubiquitous in the environment. Humans around the world have daily exposures to it indoors and outdoors from multiple sources. To date, The Procter & Gamble Company has not received any reports of adverse events related to this recall and is conducting this recall out of an abundance of caution.”
Procter & Gamble’s recall is a reminder that the “experts” constantly make mistakes and put people’s health at risk, even though they claim sole authority on the “science.”
In September, after the FDA’s approval of the Pfizer-BioNTech mRNA prophylactic therapeutic for Covid-19 (widely referred to as a “vaccine”), Pfizer recalled one of its drugs linked to cancer: The anti-smoking aid Chantix.
“Pfizer is voluntarily recalling all lots of Chantix 0.5 mg and 1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, at or above the FDA interim acceptable intake limit,” the manufacturer said in a statement. “As alternative suppliers have been approved in the United States, Pfizer is undertaking this precautionary measure.”
“Long-term ingestion of N-nitroso-varenicline may be associated with a theoretical potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication,” the statement continued. “The health benefits of stopping smoking outweigh the theoretical potential cancer risk from the nitrosamine impurity in varenicline.”
In December, the FDA issued a strict set of warnings about another Pfizer product: A class of anti-inflammatory treatments called JAK inhibitors.
“The U.S. health regulator has added its strictest warning to the labels of drugs from Pfizer, Eli Lilly and AbbVie belonging to a class of anti-inflammatory treatments called JAK inhibitors, citing risk of serious health issues and death in patients 50 and over,” Reuters reported on Friday, citing the drug manufacturers.
Despite the mRNA vaccines being mandated by the federal government and in several states, it is a verifiable fact that side effects have been vastly underreported through the VAERS system.
The Wildfire Newsletter is a free and paid subscription service provided by independent journalist Kyle Becker. Never miss an issue!